Page last updated: 2024-11-13

sulphenazone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sulphenazone: sulfamethoxypyridazine reacted with sodium salt of hydrosulfonic acid from 4-formalphenazone (antipyretic); structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23683220
MeSH IDM0042524

Synonyms (18)

Synonym
13061-27-3
sulphenazone
unii-x8l9c3d933
sodium 2,3-dihydro-alpha-((4-(((6-methoxypyridazin-3-yl)amino)sulphonyl)phenyl)amino)-1,5-dimethyl-3-oxo-2-phenyl-1h-pyrazole-4-methanesulphonate
einecs 235-953-3
x8l9c3d933 ,
sulfamazone sodium
sodium .alpha.-(p-((6-methoxy-3-pyridazinyl)sulfamoyl)anilino)-2,3-dimethyl-5-oxo-1-phenyl-3-pyrazoline-4-methanesulphonate
(+/-)-sulfamazone sodium
marespin
sulfamazone sodium [mart.]
sulfamazone sodium [who-dd]
1h-pyrazole-4-methanesulfonic acid, 2,3-dihydro-.alpha.-((4-(((6-methoxy-3-pyridazinyl)amino)sulfonyl)phenyl)amino)-1,5-dimethyl-3-oxo-2-phenyl-, sodium salt (1:1)
sodium (1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1h-pyrazol-4-yl){4-[(6-methoxypyridazin-3-yl)sulfamoyl]anilino}methanesulfonate
DTXSID60926833
Q27293690
sodium;(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-[4-[(6-methoxypyridazin-3-yl)sulfamoyl]anilino]methanesulfonate
sodium 2,3-dihydro-alpha-[[4-[[(6-methoxypyridazin-3-yl)amino]sulphonyl]phenyl]amino]-1,5-dimethyl-3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (60.00%)4.05%
Observational0 (0.00%)0.25%
Other2 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]